Jung S, Johnson DB. Management of acral and mucosal melanoma: medical oncology perspective. Oncologist. 2022;27(8):703–10.
Article PubMed PubMed Central Google Scholar
Sanad MH, Abelrahman MA, Marzook FM. Radioiodination and biological evaluation of levalbuterol as a new selective radiotracer: a β2-adrenoceptor agonist. Radiochim Acta. 2016;04(5):345–53.
Rizvi SFA, Zhang H, Mehmood S, Sanad M. Synthesis of (99m)Tc-labeled 2-Mercaptobenzimidazole as a novel radiotracer to diagnose tumor hypoxia. Transl Oncol. 2020;13(12): 100854.
Article PubMed PubMed Central Google Scholar
Sanad MH, Farag AB, Salama DH. Radioiodination and bioevaluation of rolipram as a tracer for brain imaging: In silico study, molecular modeling and gamma scintigraphy. J Labelled Comp Radiopharm. 2018;61(6):501–8.
Article CAS PubMed Google Scholar
Coghi P, Li J, Hosmane NS, Zhu Y. (2023) Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment. Med Res Rev. 43:1809
Dymova MA, Taskaev SY, Richter VA, Kuligina EV. Boron neutron capture therapy: Current status and future perspectives. Cancer Commun (Lond). 2020;40(9):406–21.
Wang LW, Liu YH, Chou FI, Jiang SH. Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor. Cancer Commun (Lond). 2018;38(1):37.
Hirose K, Konno A, Hiratsuka J, et al. Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan ((10)B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial. Radiother Oncol. 2021;155:182–7.
Article CAS PubMed Google Scholar
Li J, Sun Q, Lu C, et al. Boron encapsulated in a liposome can be used for combinational neutron capture therapy. Nat Commun. 2022;13(1):2143.
Article CAS PubMed PubMed Central Google Scholar
Cheng X, Li F, Liang L. Boron neutron capture therapy: clinical application and research progress. Curr Oncol. 2022;29(10):7868–86.
Article PubMed PubMed Central Google Scholar
Barth RF, Mi P, Yang W. Boron delivery agents for neutron capture therapy of cancer. Cancer Commun (Lond). 2018;38(1):35.
Barth RF, Coderre JA, Vicente MG, Blue TE. Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res. 2005;11(11):3987–4002.
Article CAS PubMed Google Scholar
Hartman T, Carlsson J. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy. Radiother Oncol. 1994;31(1):61–75.
Article CAS PubMed Google Scholar
Li S, Hou X, Ma Y, Wang Z. Phenylboronic-acid-based functional chemical materials for fluorescence imaging and tumor therapy. ACS Omega. 2022;7(3):2520–32.
Article CAS PubMed PubMed Central Google Scholar
Wang R, Yin C, Liu C, et al. Phenylboronic acid modification augments the lysosome escape and antitumor efficacy of a cylindrical polymer brush-based prodrug. J Am Chem Soc. 2021;143(49):20927–38.
Article CAS PubMed Google Scholar
Chen J, Dai Q, Yang Q, et al. Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma. J Nanobiotechnology. 2022;20(1):102.
Article PubMed PubMed Central Google Scholar
Wang J, Wu W, Zhang Y, et al. The combined effects of size and surface chemistry on the accumulation of boronic acid-rich protein nanoparticles in tumors. Biomaterials. 2014;35(2):866–78.
Article CAS PubMed Google Scholar
Fern J, Schulman R. Modular DNA strand-displacement controllers for directing material expansion. Nat Commun. 2018;9(1):3766.
Article PubMed PubMed Central Google Scholar
Chen J, Yang Q, Liu M, et al. Remarkable Boron Delivery Of iRGD-modified polymeric nanoparticles for boron neutron capture therapy. Int J Nanomedicine. 2019;14:8161–77.
Article CAS PubMed PubMed Central Google Scholar
Tang R, Wang M, Ray M, et al. Active targeting of the nucleus using nonpeptidic boronate tags. J Am Chem Soc. 2017;139(25):8547–51.
留言 (0)